BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 32337377)

  • 1. The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts.
    Ansems M; Span PN
    Clin Transl Radiat Oncol; 2020 May; 22():90-97. PubMed ID: 32337377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
    Martinez-Zubiaurre I; Hellevik T
    Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy.
    Taeb S; Ashrafizadeh M; Zarrabi A; Rezapoor S; Musa AE; Farhood B; Najafi M
    Curr Cancer Drug Targets; 2022; 22(1):18-30. PubMed ID: 34951575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunobiology of cancer-associated fibroblasts in the context of radiotherapy.
    Hellevik T; Berzaghi R; Lode K; Islam A; Martinez-Zubiaurre I
    J Transl Med; 2021 Oct; 19(1):437. PubMed ID: 34663337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
    Piper M; Mueller AC; Karam SD
    Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment.
    Xiong Y; McDonald LT; Russell DL; Kelly RR; Wilson KR; Mehrotra M; Soloff AC; LaRue AC
    World J Stem Cells; 2015 Mar; 7(2):253-65. PubMed ID: 25815113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
    Pradip D; Jennifer A; Nandini D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
    Allam A; Yakou M; Pang L; Ernst M; Huynh J
    Front Immunol; 2021; 12():767939. PubMed ID: 34858425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer.
    Dayan D; Salo T; Salo S; Nyberg P; Nurmenniemi S; Costea DE; Vered M
    Cancer Med; 2012 Oct; 1(2):128-40. PubMed ID: 23342263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAF-immune cell crosstalk and its impact in immunotherapy.
    Maia A; Schöllhorn A; Schuhmacher J; Gouttefangeas C
    Semin Immunopathol; 2023 Mar; 45(2):203-214. PubMed ID: 36480035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.
    De P; Aske J; Sulaiman R; Dey N
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranilast inhibits the function of cancer-associated fibroblasts responsible for the induction of immune suppressor cell types.
    Ohshio Y; Hanaoka J; Kontani K; Teramoto K
    Scand J Immunol; 2014 Dec; 80(6):408-16. PubMed ID: 25224016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irradiated Tumor Fibroblasts Avoid Immune Recognition and Retain Immunosuppressive Functions Over Natural Killer Cells.
    Yang N; Lode K; Berzaghi R; Islam A; Martinez-Zubiaurre I; Hellevik T
    Front Immunol; 2020; 11():602530. PubMed ID: 33584669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy.
    Piwocka O; Piotrowski I; Suchorska WM; Kulcenty K
    Front Mol Biosci; 2024; 11():1343523. PubMed ID: 38455762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer associated fibroblasts tailored tumor microenvironment of therapy resistance in gastrointestinal cancers.
    Sun Y; Wang R; Qiao M; Xu Y; Guan W; Wang L
    J Cell Physiol; 2018 Sep; 233(9):6359-6369. PubMed ID: 29334123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Immune Infiltration of Ovarian Cancer Tumor Microenvironment by Specific Subpopulations of Fibroblasts.
    Wang J; Cheng FHC; Tedrow J; Chang W; Zhang C; Mitra AK
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33138184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case for cancer-associated fibroblasts: essential elements in cancer drug discovery?
    Brewer G; Fortier AM; Park M; Moraes C
    Future Drug Discov; 2022 Jan; 4(1):FDD71. PubMed ID: 35600290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts: Secretions, interactions, and therapy.
    Farhood B; Najafi M; Mortezaee K
    J Cell Biochem; 2019 Mar; 120(3):2791-2800. PubMed ID: 30260049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.